)
Max Wang
BD
Mote Therapeutics
Max Wang is a biotechnology business development and portfolio management professional with over 10 years of experience across biologics, cell and gene therapeutics, oncology, and immunology.
He currently supports business development at Mote Therapeutics and Fapon Biopharma, driving partnerships and strategic initiatives for next-generation therapeutic platforms — including targeted LNP delivery, T-cell engagers, and immune cytokine fusions.
Previously, Max held business development and portfolio management roles at Ansun Biopharma, Transcenta Holding, and WuXi Biologics, where he focused on global partnering, biologics development, and strategic collaborations.
Max holds a PhD in Biochemistry and an MBA in Finance and Strategy, both from The Ohio State University, where his doctoral research centered on membrane protein biogenesis.
Sessions
-
22-Jun-2026Theater 3Mote Therapeutics, Inc.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}